AU3611000A - Thiazoloindolinone compounds - Google Patents

Thiazoloindolinone compounds Download PDF

Info

Publication number
AU3611000A
AU3611000A AU36110/00A AU3611000A AU3611000A AU 3611000 A AU3611000 A AU 3611000A AU 36110/00 A AU36110/00 A AU 36110/00A AU 3611000 A AU3611000 A AU 3611000A AU 3611000 A AU3611000 A AU 3611000A
Authority
AU
Australia
Prior art keywords
compound
thiazolindolinone
methyl
thiazolo
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36110/00A
Other languages
English (en)
Inventor
Ambrish Vyas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU3611000A publication Critical patent/AU3611000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
AU36110/00A 1999-03-04 2000-03-01 Thiazoloindolinone compounds Abandoned AU3611000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9904930.6A GB9904930D0 (en) 1999-03-04 1999-03-04 Thiazoloindolinone compounds
GB9904930 1999-03-04
PCT/US2000/005192 WO2000052013A2 (fr) 1999-03-04 2000-03-01 Composes thiazolo-indolinoniques

Publications (1)

Publication Number Publication Date
AU3611000A true AU3611000A (en) 2000-09-21

Family

ID=10848912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36110/00A Abandoned AU3611000A (en) 1999-03-04 2000-03-01 Thiazoloindolinone compounds

Country Status (18)

Country Link
EP (1) EP1159280A2 (fr)
JP (1) JP2003532620A (fr)
KR (1) KR20020005606A (fr)
CN (1) CN1355807A (fr)
AU (1) AU3611000A (fr)
BR (1) BR0008677A (fr)
CA (1) CA2361580A1 (fr)
CZ (1) CZ20013187A3 (fr)
GB (1) GB9904930D0 (fr)
HK (1) HK1041692A1 (fr)
HU (1) HUP0200376A3 (fr)
IL (1) IL144808A0 (fr)
MX (1) MXPA01008910A (fr)
NO (1) NO20014262L (fr)
PL (1) PL351476A1 (fr)
TR (1) TR200102557T2 (fr)
WO (1) WO2000052013A2 (fr)
ZA (1) ZA200106826B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
JP2007519758A (ja) * 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 結晶マクロライドの生成方法
UA103319C2 (en) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および/または治療剤
WO2011125763A1 (fr) 2010-03-31 2011-10-13 小野薬品工業株式会社 Agent préventif et/ou remède pour le syndrome d'enflure douloureuse des mains et des pieds
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーOnquality Pharmaceuticals China Ltd. Egfr阻害に関連する疾患を予防又は治療する方法
CA3097067A1 (fr) 2018-04-16 2019-10-24 Onquality Pharmaceuticals China Ltd. Methode pour prevenir ou traiter les effets secondaires d'une cancerotherapie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984930B1 (fr) * 1997-05-07 2005-04-06 Sugen, Inc. Derives de 2-indolinone utilises en tant que modulateurs de l'activite de la proteine kinase
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
JP2003532620A (ja) 2003-11-05
IL144808A0 (en) 2002-06-30
TR200102557T2 (tr) 2007-01-22
EP1159280A2 (fr) 2001-12-05
KR20020005606A (ko) 2002-01-17
NO20014262D0 (no) 2001-09-03
WO2000052013A2 (fr) 2000-09-08
ZA200106826B (en) 2003-02-25
GB9904930D0 (en) 1999-04-28
NO20014262L (no) 2001-10-30
CZ20013187A3 (cs) 2002-02-13
HK1041692A1 (zh) 2002-07-19
CN1355807A (zh) 2002-06-26
MXPA01008910A (es) 2002-03-27
WO2000052013A3 (fr) 2000-12-28
PL351476A1 (en) 2003-04-22
CA2361580A1 (fr) 2000-09-08
HUP0200376A3 (en) 2003-07-28
HUP0200376A2 (en) 2002-06-29
BR0008677A (pt) 2002-01-08

Similar Documents

Publication Publication Date Title
ES2199156T3 (es) Derivados de aza-oxindol sustituidos.
EP1732920B1 (fr) Derives du thiophene en tant qu'inhibiteurs chk1
AU781028B2 (en) Imidazo (1,3,5) triazinones and the use thereof
US7538113B2 (en) 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
CZ139097A3 (cs) 6-Arylpyrido[2,3-d]pyrimidiny a naftyridiny a farmaceutické prostředky na jejich bázi
EP2522670A1 (fr) Antagonistes hétérocycliques des récépteurs du CRF
US20040180897A1 (en) Novel tyrosine kinase inhibitors
US6624171B1 (en) Substituted aza-oxindole derivatives
AU2012240026A1 (en) Methods and compositions for treating neurodegenerative diseases
PL165502B1 (pl) Sposób wytwarzania nowych pochodnych aminopirymidyny PL PL PL PL PL
CA2674875A1 (fr) Derives de purine
JP6797923B2 (ja) Alkおよびsrpk阻害剤ならびに使用方法
EP3892621B1 (fr) Composés d'halogénoallylamine et leur utilisation
EP1325009B1 (fr) Composes tetracycliques amino-substitues utiles en tant qu'agents anti-inflammatoires et compositions pharmaceutiques les contenant
WO2004016605A1 (fr) Derives de 2-aminopyrimidine utilises en tant qu'antagonistes des recepteurs a2a et a1 de l'adenosine
US6683081B2 (en) Triazolotriazinones and the use thereof
KR20010006509A (ko) 5,7-이치환된 4-아미노피리도[2,3-d]피리미딘 화합물 및 아데노신 키나제 억제제로서의 이의 용도
AU3611000A (en) Thiazoloindolinone compounds
US6492398B1 (en) Thiazoloindolinone compounds
CA2438113A1 (fr) Imidazotriazinones 2-alcoxyphenyl-substituees
CN113004305A (zh) 大环化合物及其制备方法和用途
CN113004284B (zh) 作为血浆激肽释放酶抑制剂的四环类化合物及其用途
WO2021168341A1 (fr) Formes solides de 1-(5-(3-(7-(3-fluorophényl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-diméthylméthanamine
KR100282153B1 (ko) 3-알킬피롤록3,2-씨퀴놀린유도체
CN112079836A (zh) 三唑并嘧啶类化合物及其盐、组合物和应用

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted